Enlighta Inc. announced the appointment of John F. Wallace and Dr. Christina Gong as - Independent Directors of the Company. John will also serve as Chairman of the Board and Chair of the Audit Committee. John is Chairman and CEO of Philadelphia Financial Services, LLC ("PFS").

His company provides consulting services to firms in the financial services industry. For the majority of his career, John was a senior executive and officer of the Philadelphia Stock Exchange ("PHLX"). John started at the PHLX in 1964, and became a member of the PHLX in 1971.

John served as a member of the PHLX Board of Governors from 1984 until August 2008. During his tenure at the PHLX John held several senior positions including Chairman, Vice Chairman and Chief Executive Officer. John also served as Chairman of the Board of the Stock Clearing Corporation of Philadelphia, Chairman of the Board of the Philadelphia Board of Trade, Chairman of the Board of the Philadelphia Depository Corporation and board member of the PHLX's technology subsidiary, Advanced Tech Source Company.

Over the course of his career in the securities industry, John has also been a member of the Toronto Stock Exchange, a seat owner of the New York Mercantile Exchange as well as registered with the National Futures Association as a floor broker. John is a graduate of Franklin &Marshall College. He served for 28 years in the United States Army, the Army Reserve and the Army National Guard; he retired holding the rank of Lieutenant Colonel.

John saw active duty in Grenada in 1983 with 1st Special Operations Command and Desert Storm from December 1990 to July 1991 with the Third U.S. Army. He is a graduate of the United States Army Command and General Staff College and the National Emergency Management Institute of the Federal Emergency Management Agency (FEMA). Dr. Gong has a rich experience in healthcare and pharmaceutical industry.

Dr. Gong is Adjunct Professor in the China Academy of Management Science and a member of the China Anti-Cancer Association (CACA). Dr. Gong previously served as country lead and senior manager of Novartis China, responsible for market access strategy of multiple oncology products. Dr. Gong completed her medical education with Central South University and received her clinical training in surgical oncology at Peking University Cancer Hospital and surgery at Peking University First Hospital.

Dr. Gong also holds a master degree in Oncology from Peking University, a PhD degree in Bioengineering from the University of Illinois. Dr. Gong was invited to many lectures and international conferences around the world, and published many papers in academic journals.